Globus Medical stock downgraded to “sell” by Goldman Sachs: 3 points

Goldman Sachs downgraded Globus Medical stock to a “sell” rating, according to a report by The Market Digest.

Advertisement

Here are three points:

 

1. The investment firm previously rated Globus Medical stock as “neutral.”

 

2. The company has a market cap of $2.8 billion.

 

3. On May 13, Globus Medical opened for trading at $23.40 and ended the session at $23.53.

 

More articles on devices:
Misonix revenue reaches $5.4M in Q3: 8 highlights
RTI Surgical outlines why stockholders should elect its director nominees on WHITE proxy card: 5 points
Stryker, Smith & Nephew, K2M & more: 18 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.